By the end of four weeks, the shRNA-free tumors grew to an average size of 2,747.7 mm3 whereas the shRNA-CAV1-1 403.6 mm3, being an approximately 65% inhibition in tumor growth statistically (Fig. 3C and 3D). The gene discussed is CAV1; the disease is neoplasm.